Platinum Equity Acquires Controlling Stake in Inventia Healthcare
August 29, 2024
Platinum Equity has acquired a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business from India Life Sciences Fund III (advised by InvAscent), NYLIM Jacob Ballas India Fund III and affiliates of the founding Shah family, with the Shah family retaining a minority stake. Headquartered in Mumbai, Inventia is a U.S. FDA- and MHRA-accredited contract manufacturer and developer of generic OSD products serving more than 100 customers across 40+ countries; Platinum plans to expand the business organically and via add-on acquisitions.
- Buyers
- Platinum Equity
- Targets
- Inventia Healthcare Limited
- Sellers
- India Life Sciences Fund III (advised by InvAscent), NYLIM Jacob Ballas India Fund III, LLC, Affiliates of the Shah family
- Industry
- Pharmaceuticals
- Location
- Maharashtra, India
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Platinum Equity Acquires ASP Global
August 6, 2024
Healthcare Services
Platinum Equity has acquired ASP Global, an Atlanta-based developer, sourcer and distributor of consumable medical products for healthcare providers and distributors, from Incline Equity Partners. Financial terms were not disclosed; ASP Global CEO Doug Shaver will remain in place as Platinum Equity commits capital and M&A/operational resources to support the company’s continued growth and expansion.
-
Platinum Equity Acquires Sunrise Medical from Nordic Capital
October 16, 2024
Medical Devices
Platinum Equity has signed a definitive agreement to acquire Sunrise Medical Group, a Germany-headquartered global manufacturer and distributor of assistive mobility products, from Nordic Capital. The buyout (expected to close in Q3 2024) positions Platinum to pursue a buy-and-build strategy to expand Sunrise's geographic footprint—particularly in North America—and to accelerate product and operational investments.
-
SAI MedPartners Acquires IDEA Pharma
November 14, 2024
Healthcare Services
SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.
-
Everstone Capital Acquires Controlling Stake in Softgel Healthcare
September 14, 2022
Pharmaceuticals
Everstone Capital has acquired a controlling (majority) stake in Softgel Healthcare Private Limited (SHPL), a Chennai-headquartered CDMO specializing in soft gelatin capsules and probiotics and part of the Madras Pharma Group. The investment will support SHPL's global expansion and capability development across pharmaceutical, nutraceutical and OTC markets, with Everstone partners joining the company's board.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
EQT, Silver Lake and Nestlé Expand Partnership with €3.5bn Investment in IVC Evidensia
February 9, 2021
Veterinary
IVC Evidensia has secured an aggregated new investment of €3.5 billion that values the company at an enterprise value of approximately €12.3 billion. The expanded partnership includes a substantial reinvestment by EQT Private Equity, a new minority investment from Silver Lake, and an increased minority stake from Nestlé Purina PetCare EMENA to support digitalisation and further growth across IVC's network of clinics.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.